Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04437628

Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Wonju Severance Christian Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Several surrogate biomarkers including natriuretic peptide(NP), and growth differentiation factor-15(GDF-15) and ST2 has prognostic significance in heart failure(HF), and reductions in its value may predict clinical improvement. However, there are limited data regarding the prognostic value of these biomarkers during short-term follow-up after discharge in acute decompensated heart failure. The purpose of this study is to evaluate the prognostic value of short-term follow-up surrogate biomarkers for predicting prognosis of hospitalized patients with acute decompensated heart failure.

Conditions

Timeline

Start date
2021-02-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2020-06-18
Last updated
2024-09-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04437628. Inclusion in this directory is not an endorsement.

Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure (NCT04437628) · Clinical Trials Directory